Arkolith/Insider Trading/ADIL/Form 4

Newman James W. Jr.

DirectorADIAL PHARMACEUTICALS, INC. (ADIL) · full profile →Form 4 · filed Jan 3, 2022
Net Buying
Open-Market Buys
$67K
Open-Market Sells
$0
Net Open-Market Flow
$67K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 30, 2021Buy(P)10K$2.66$27K20K
Dec 30, 2021Buy(P)5K$2.72$14K50K
Dec 30, 2021Buy(P)10K$2.71$27K35K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-22-000067) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML